StonvexLoading…
StonvexStonvexStonvexCore line items from NKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $35.43B | $24.15B | $11.72B | $46.31B |
Operating Income | $2.57B | $1.92B | $922.00M | $3.88B |
Net Income | $2.04B | $1.52B | $727.00M | $3.22B |
EPS (Diluted) | $1.38 | $1.03 | $0.49 | $2.16 |
Total Assets | $37.06B | $37.79B | $37.33B | $36.58B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.66B | $6.97B | $7.02B | $7.46B |
Free Cash Flow OCF − CapEx | $685.00M | $401.00M | $15.00M | $3.27B |
Shares Outstanding | 1.48B | 1.48B | 1.48B | 1.49B |